Phase II Randomized Trial Evaluating the Administration of Sorafenib or Pravastatin or Association Sorafenib-pravastatin or Best Supportive Care for the Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis.
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2018
At a glance
- Drugs Pravastatin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms PRODIGE 21
- 14 Apr 2018 Results presented at The International Liver Congress 2018
- 28 Apr 2017 Status changed from active, no longer recruiting to completed.
- 22 Jun 2016 Planned primary completion date changed from 1 Aug 2015 to 1 Nov 2016.